Vaxcyte (PCVX) Operating Leases (2021 - 2026)
Vaxcyte (PCVX) posted Operating Leases of $108.94 million for Q2 2026, up 37.0% from $79.54 million a year earlier but down 1.2% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte's Operating Leases came in at $111.46 million, up 70.9% from FY2024.
- Annual Operating Leases has increased for four consecutive years, with a four-year compound annual growth rate of 76.4% (FY2021 to FY2025).
- In prior years, Vaxcyte's Operating Leases was $65.22 million in FY2024 (+195.0%), $22.11 million in FY2023 (+83.8%), $12.03 million in FY2022 (+4.6%) and $11.51 million in FY2021.
- Quarterly Operating Leases has run from a low of $553,000 in Q3 2021 to a high of $111.46 million in Q4 2025 over five years.
- On a year-over-year basis, Operating Leases has increased in each of the last 11 quarters, with growth averaging 179.9% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2025, with growth of 334.9%; the weakest was Q3 2023, with a decline of 41.7%.
- According to Business Quant data, Operating Leases for the three prior quarters was $110.21 million (Q1 2026), $111.46 million (Q4 2025) and $78.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.94 Mn |
| Mar 31, 2026 | 110.21 Mn |
| Dec 31, 2025 | 111.46 Mn |
| Sep 30, 2025 | 78.67 Mn |
| Jun 30, 2025 | 79.54 Mn |
| Mar 31, 2025 | 81.08 Mn |
| Dec 31, 2024 | 65.22 Mn |
| Sep 30, 2024 | 18.32 Mn |
| Jun 30, 2024 | 18.29 Mn |
| Mar 31, 2024 | 20.22 Mn |
| Dec 31, 2023 | 22.11 Mn |
| Sep 30, 2023 | 7.78 Mn |
| Jun 30, 2023 | 9.22 Mn |
| Mar 31, 2023 | 10.64 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 13.36 Mn |
| Jun 30, 2022 | 14.56 Mn |
| Mar 31, 2022 | 15.83 Mn |
| Dec 31, 2021 | 11.51 Mn |
| Sep 30, 2021 | 553,000.00 |
API Access
Vaxcyte Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();